Clinical protocol for a multicentre, double-blind, randomised study on the efficacy, safety and tolerability of Valdecoxib 40 mg once daily and Nimesulide 100 mg twice daily in the symptomatic treatment of patients with pharyngitis.

Multinational, multicenter clinical study to compare the efficacy of two non-steroidal anti-inflammatory drugs (Valdecoxib and Nimesulide) in the treatment of viral pharyngitis. This is a comparison of a new drug type COX-2 inhibitor (Valdecoxib) with an anti-inflammatory of previous use.